Documentos relacionados

1. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.
2. Oral Abundance of Actinomyces spp. in Breast Cancer Patients.
3. The assessment of halitosis with a new screening tool in medication-related osteonecrosis of the jaw.
4. Pentoxifylline and tocopherol as prophylaxis for osteonecrosis of the jaw due to bone-modifying agents in patients with cancer submitted to tooth extraction: a case series.
5. [Medication-related osteonecrosis of the jaws associated with the use of bone-modifying agents].
6. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
7. Borate bioactive glass prevents zoledronate-induced osteonecrosis of the jaw by restoring osteogenesis and angiogenesis.
8. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
9. Bisphosphonate-related osteonecrosis of the jaw: Current clinical significance and treatment strategy review.
10. Spontaneous Recovery of Pathological Fracture Caused by Medication-Related Osteonecrosis of the Jaw.